Nomura Holdings Inc Halozyme Therapeutics, Inc. Call Options Transaction History

Nomura Holdings Inc

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$37.81 - $52.4 $1.03 Million - $1.43 Million	27,200 Added 37.88%	99,000 $5.18 Million
Q1 2024 May 15, 2024	BUY	$33.68 - $41.95 $2.42 Million - $3.01 Million	71,800 New	71,800 $2.92 Million
Q4 2023 Feb 14, 2024	BUY	$33.32 - $42.1 $1.4 Million - $1.77 Million	42,000 New	42,000 $1.55 Million
Q4 2022 Feb 14, 2023	BUY	$40.06 - $59.44 $3.3 Million - $4.9 Million	82,500 New	82,500 $4.69 Million
Q4 2020 Feb 16, 2021	SELL	$25.81 - $43.62 $1.05 Million - $1.77 Million	-40,500 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$25.74 - $29.63 $1.04 Million - $1.2 Million	40,500 New	40,500 $1.06 Million

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.57B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.